Comparison of 1-year clinical results of transcatheter aortic valve replacement (TAVR) using prostheses with two different frame designs in 124 patients in a single center
- VernacularTitle:两种不同支架经导管主动脉瓣置换术（TAVR）单中心 124 例一年临床效果的比较
- Author:
Peide ZHANG
1
;
Fei LI
2
;
Xu WANG
2
;
Donghui XU
2
;
Yuetang WANG
2
;
Yongjian WU
2
;
Wei WANG
2
Author Information
1. Department of Surgical ICU, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, P.R.China
2. Department of Structural Heart Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, P.R.China
- Publication Type:Journal Article
- Keywords:
Artifical stent valve;
transcatheter aortic valve replacement (TAVR);
permanent pacemaker implantation;
short-term prognosis;
intervention treatment
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2021;28(08):895-900
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare and analyze the clinical effects of two kinds of frame design valves after transcatheter aortic valve replacement (TAVR). Methods We retrospectively reviewed 124 patients who underwent TAVR and were followed up for 1 year. There were 71 males and 53 females aged 75.57±6.21 years. These patients were treated with Venus-A or Edwards Sapien aortic valves. The hemodynamics and cardiac function of these two kinds of transcatheter aortic valves (THV) were evaluated by echocardiography. The 30-day mortality and 1-year clinical effect of the patients were calculated. Results Eight-one patients used Venus-A valve and 43 patients used Edwards Sapien valve. The aortic valve transaortic pressure gradient was reduced and the rate of perivalvular leakage was low (both 2.6%) in both groups, and there was no statistical difference between the two groups. The implantation rate of permanent pacemaker was 17.3% and 11.6%, respectively. The 1-month survival (94.0% and 93.0%) and 1-year survival (94.0% and 91.0%) rates were not statistically different. Conclusion The two groups of THV with different stent structures have good short-term clinical effect and low implantation rate of permanent pacemaker.
